ANTIBODY-GUIDED RADIOLOCALIZATION OF TUMORS IN PATIENTS WITH TESTICULAR OR OVARIAN-CANCER USING 2 RADIOIODINATED MONOCLONAL-ANTIBODIES TO PLACENTAL ALKALINE-PHOSPHATASE
ANTIBODY-GUIDED RADIOLOCALIZATION OF TUMORS IN PATIENTS WITH TESTICULAR OR OVARIAN-CANCER USING 2 RADIOIODINATED MONOCLONAL-ANTIBODIES TO PLACENTAL ALKALINE-PHOSPHATASE
复制标题
DOI:
10.1259/0007-1285-59-698-117
复制
发表时间:
1986-02-01
影响因子:
2.6
通讯作者:
LAVENDER, JP
中科院分区:
文献类型:
--
作者:
EPENETOS, AA;CARR, D;LAVENDER, JP
Monoclonal antibodies (H317 and H17E2) against placental-type alkaline phosphatase and testicular placental-like alkaline phosphatase were radiolabelled with 123I or 131I and used in a prospective study of patients with germ-cell neoplasms of the testis (13 studies) or epithelial-origin neoplasms of the ovary (13 studies). The presence of tumour was confirmed in the majority of patients with active disease by antibody scanning. The absence of tumor was confirmed in all cases in patients in complete remission. In two patients with positive antibody scans but no disease found by conventional radiological evaluation, further investigation subsequently revealed the presence of tumor. A positive antibody scan indicates the definite presence of a tumour, although a negative antibody scan does not always exclude the presence of disease. This method may be of clinical value in establishing disease status in patients with potentially curable diseases such ovarian or testicular cancers.